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Background: Therapeutic inertia has been defined as the failure of health-care provider to initiate or intensify therapy
when therapeutic goals are not reached. It is regarded as a major cause of uncontrolled hypertension. The exploration of
its causes and the interventions to reduce it are plagued by unclear conceptualizations and hypothesized mechanisms.
We therefore systematically searched the literature for definitions and discussions on the concept of therapeutic inertia
in hypertension in primary care, to try and form an operational definition.
Methods: A systematic review of all types of publications related to clinical inertia in hypertension was performed.
Medline, EMbase, PsycInfo, the Cochrane library and databases, BDSP, CRD and NGC were searched from the start of
their databases to June 2013. Articles were selected independently by two authors on the basis of their conceptual
content, without other eligibility criteria or formal quality appraisal. Qualitative data were extracted independently by
two teams of authors. Data were analyzed using a constant comparative qualitative method.
Results: The final selection included 89 articles. 112 codes were grouped in 4 categories: terms and definitions
(semantics), “who” (physician, patient or system), “how and why” (mechanisms and reasons), and “appropriateness”.
Regarding each of these categories, a number of contradictory assertions were found, most of them relying on little or
no empirical data. Overall, the limits of what should be considered as inertia were not clear. A number of authors
insisted that what was considered deleterious inertia might in fact be appropriate care, depending on the situation.
Conclusions: Our data analysis revealed a major lack of conceptualization of therapeutic inertia in hypertension and
important discrepancies regarding its possible causes, mechanisms and outcomes. The concept should be split in two
parts: appropriate inaction and inappropriate inertia. The development of consensual and operational definitions relying
on empirical data and the exploration of the intimate mechanisms that underlie these behaviors are now needed.
Keywords: Hypertension, Primary care, Quality of health care, Systematic review, Therapeutic inertiaBackground
The burden of uncontrolled hypertension
The burden of hypertension weighs heavily on pub-
lic health in all industrialized countries [1]. Surveys in
Europe and North America show prevalences of 40–80%
in patients aged 35–64 years [2]. Hypertension leads to a
major risk of stroke and acute myocardial infarction (AMI),
with morbidity and mortality increasing linearly with* Correspondence: jean-pierre.lebeau@univ-tours.fr
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unless otherwise stated.increases in both systolic and diastolic blood pressure
(BP) [3]. At the same time, there is strong evidence for
the major benefits of treating hypertensive patients, result-
ing in a reduced risk of up to 15% for AMI, 40% for
stroke, and 30% for cardiovascular mortality [4].
Considering this evidence, a number of guidelines have
been published on the diagnosis, treatment, and follow-
up of hypertensive adult patients, either by health au-
thorities or by scientific colleges and societies [5-7]. The
way drugs should be used and combined, the treatment
targets, and elements of the patients’ education andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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in these guidelines.
Despite this clearly codified and evidence-based as-
sessment, real-life primary care shows quite disappoint-
ing results. The classical rule of halves still holds in
most European countries: approximately half of the pa-
tients with a diagnosis of hypertension are not treated
and half of those who are treated do not reach set targets
[8]. Although the situation is somewhat better in the US,
where two-thirds of the diagnosed patients reach the
therapeutic goals, there is still room for improvement [9].
A number of reasons can be put forward to explain
these poor results: many are related to the health system
and to the patients (notably adherence to treatment).
Other reasons are related to health-care providers, and
particularly to clinical inertia.
Clinical and therapeutic inertia
Clinical inertia was initially defined in 2001 by Phillips
[10]. According to this definition, clinical inertia applies
only to the management of risk factors, when thera-
peutic targets are clearly defined and the benefits to
reach those targets are well established. Effective therap-
ies should be widely available, and practice guidelines
disseminated extensively. Clinical inertia appears when-
ever the health-care provider does not initiate or inten-
sify therapy appropriately when therapeutic goals are not
reached: “recognition of the problem, but failure to act”.
Phillips described three main sets of reasons for thera-
peutic inertia: overestimation of care, soft reasons (i.e. “im-
proving control”, “target almost reached”, etc.), and lack of
training and organization in the practice at “treating to tar-
get”. Subsequent articles added clinical uncertainty [11]
and competing demands [12] as other reasons for clinical
inertia. This initial definition was Phillips’ own idea, and
was produced on a deductive basis. With the exact same
definition, Okonufa et al. introduced the terms “therapeutic
inertia” in 2006 [13]. Since then, the terms “clinical inertia”
and “therapeutic inertia” have been used indistinctly (we
chose to use the latter in this article). Neither of them, nor
“inertia” alone, is a Medical Subject Heading (MeSH) term.
Clinical inertia as defined by Phillips has become in-
creasingly acknowledged as a major impediment to reach-
ing both individual and public-health targets for a number
of risk factors [13]. Hypertensive patients, in particular, ex-
perience therapeutic inertia from their physician in up to
85% of visits in some European countries [9]. On the
other hand, Phillips et al. themselves gave a note of cau-
tion in their paper that exceptions occur and that appro-
priate care should allow individualization: “the uniform
application of guidelines for patient management could re-
sult in overtreatment or inappropriate action” [10].
Since then, this major ambivalence nested in the core
of the concept has plagued all research on mechanismsand outcomes of clinical or therapeutic inertia, and all
experimental attempts to reduce it. Very few studies
have tried to clarify the concept or to refine the defin-
ition of therapeutic inertia from empirical data, to make it
operational on an inductive basis.
We have conducted a systematic review of the literature
on therapeutic inertia in hypertension, and have looked
for elements of its definition and conceptualization.
Our aim was to come up with a clear concept and to
form an operational definition upon which clinical tri-
als could rely.Methods
As much as possible, we have tried to report this review
according to the PRISMA guidelines [14]. However, these
guidelines were designed for the report of quantitative sys-
tematic reviews and meta-analysis, and a number of item
could not be considered here.Types of studies considered for the review
Because we were looking for definitions of a recent con-
cept, we considered that every type of paper could be
eligible:
– Trials
– Surveys and epidemiological studies
– Qualitative research
– Reviews
– Opinion papers and editorials about the concept of
inertia or about guideline-implementation issuesSearch strategy for identification of studies
Databases
The following databases were searched from their begin-
nings until June 2013: Medline, EMbase, PsycInfo, the
Cochrane library and databases, BDSP (French Public
Health Database), CRD (Center for Reviews and Dissem-
ination), and NGC (National Guideline Clearinghouse).
The search algorithm for Medline (via PubMed) was:
(“guideline adherence”[MeSH Terms] OR (“practice guide-
lines as topic”[MeSH Terms] AND (“clinical audit”[MeSH
Terms] OR “clinical competence”[MeSH Terms] OR “atti-
tude of health personnel”[MeSH Terms] OR “delivery of
health care”[MeSH Terms] OR “physician’s practice pat-
terns”[MeSH Terms] OR “nurse’s practice patterns”[MeSH
Terms])) AND (“hypertension”[MeSH Terms] OR “antihy-
pertensive agents”[MeSH Terms])) OR “clinical inertia”[All
Fields] OR “therapeutic inertia”[All Fields]. The other data-
bases were searched using the same algorithm adapted to
their respective syntactic structures.
Languages were limited to English, French, Spanish,
Portuguese, German, and Dutch.
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Google Scholar was systematically searched for “clinical
inertia” and “therapeutic inertia”. All results retrieved by
searching Google with the same terms were explored. The
reference list of each selected article was systematically
screened for other relevant articles. Experts in the field
were contacted and asked for their personal databases.
Methods of the review
Abstracts selection
Two researchers (JPL and TP) reviewed independently
the titles, abstract sections, and keywords of every rec-
ord retrieved, using a score list. The article was included
if one of the following characteristics was present:
– The words “clinical inertia” or “therapeutic inertia”
appeared
– Hypertension guidelines implementation was the
main subject
– Design, assessment, or evaluation of any kind of
intervention directed to the general practitioner for
hypertension control was the main topic
– The general practitioners’ behaviors or barriers to
change regarding hypertension treatment were the
main topic.
Although these last topics were not part of the re-
search question, chances were that the concept of thera-
peutic inertia would be discussed in such articles.
Full-texts assessment
The articles were rejected if they recorded no element of
definition or conceptualization. Articles which only cited
the words “therapeutic inertia” or “clinical inertia” with
no further explanation, or which referred directly and
explicitly to the initial publication by Phillips without
any restriction or discussion about its content were rejected.
Epidemiological surveys that measured the gap between ac-
tual care for hypertension and guidelines but did not discuss
the mechanisms of poor implementation were also rejected,
as they did not provide any criteria or element of a defin-
ition for therapeutic inertia.
Agreement between the researchers was calculated
using Cohen’s kappa. Differences in opinion were re-
solved by discussion that included a third researcher
(JSC).
Process of data collection
A constant comparative qualitative method according to
grounded theory was used to collect and classify emer-
ging data from the full articles [15,16]. Units of text
(words, sentences, paragraphs) were labeled through an
open-coding process. A lexical analysis was carried out
simultaneously, which focused on the words used tocomment on inertia. Axial coding was then conducted,
which consisted of comparing and grouping codes together
into categories. Finally, through a selective coding process,
all the categories were organized hierarchically according
to their reliability and consistency, which led to an accurate
description of the emerging concepts.
Data were independently analyzed from each article by
the two teams of researchers (JPL/TP and IAA/AM),
using a qualitative analytical software package (NVivo 9.2,
QSR International Pty Ltd, Doncaster, Australia; 2011).
Discrepancies were resolved by discussion, and any dis-




The initial search of the databases resulted in a total of 2
946 abstracts: 1061 from Medline, 1732 from EMbase,
74 from PsycInfo, 77 from the Cochrane Library and
database, and 2 from the other databases. After revie-
wing the abstracts, removing duplicates, and discussion
to resolve differences in opinions, 145 abstracts were
included: 84 from Medline, 51 from EMbase, 8 from
PsycInfo, 2 from the Cochrane Library and database,
and none from the other databases (duplicates were re-
moved in this order). Systematic check of all the results
retrieved in Google with the terms “clinical inertia” (162
results) and “therapeutic inertia” (142 results) did not
lead to any new inclusion, and neither did the personal
databases of the authors and the experts we contacted.
A systematic search of the reference lists of selected arti-
cles retrieved 21 more abstracts. Inter-reviewer agree-
ment at this stage, expressed as the observed Cohen’s
kappa was 0.84 (95% CI: 0.80–0.88).
The full-texts of 165 articles were assessed and checked
for relevant content independently by two researchers
(JPL and TP): 76 did not contain any relevant information,
and 1 article could not be found (no archive kept by the
journal nor by the author). The final selection included 89
articles (Figure 1).
Types of publications and their contents
Of the 89 articles, 36 were clinical studies (8 trials, 16
cross-sectional studies, 7 cohort studies and 5 surveys),
5 were qualitative studies (including a nominal group
consensus study), 15 were literature reviews – of which
none matched the criteria of a systematic review -, 10
were editorials, and the other were experts opinion or
position articles (including commentaries and 2 letters)
(see Additional file 1).
Coding
Open coding of the relevant content of the articles re-
sulted in 112 codes. These open codes were grouped for
Figure 1 Systematic research flow chart.
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(semantics), “who” (physician, patient or system), “how and
why” (mechanisms and reasons), and “appropriateness”.
Terms and definitions
Most authors considered that “clinical inertia”, “thera-
peutic inertia” and “physician inertia” were all synonym-
ous. This was either explicit [17,18] or implicit when
Phillips’ definition of clinical inertia was quoted to define
therapeutic inertia [11] or physician inertia [19]. A few
authors, however, insisted that different terms should
mean different things: “the terms “clinical inertia” and
“therapeutic inertia” have been used recently by authors,
primarily to attribute to physicians the apparent failure
of patients to attain therapeutic blood pressure goals. We
think it would be helpful to define and differentiate these
terms” [20]. Scheen made a clear distinction, stating that:
“Therapeutic inertia is one of the components of clinical
inertia”, but gave no further explanation [21]. Giugliano
et al. made a distinction between the overall phenomenon
of clinical inertia and the part that was attributable to the
physician’s behavior: i.e., physician inertia [22], a term also
used by Krakoff et al., but without any distinction from
clinical inertia [19]. Gil-Guillén et al. separated “diagnostic
inertia” from “therapeutic inertia” : “Diagnostic inertia was
identified when a patient without known hypertension had
high blood pressure (BP) but was labeled “normal” by themedical staff, and therapeutic inertia when treatment was
not modified for a hypertensive patient on the presence of
high BP values” [23]. Vinyoles proposed three kinds of in-
ertia: “Three inertias are barriers to change: physician’s in-
ertia, patient’s inertia, and health authorities inertia”, but
the respective definitions remained implicit [24]. Discuss-
ing the synergy between patient non adherence and
healthcare provider inertia, Reach proposed “Clinical my-
opia” for the common mechanism underlying these be-
haviors [25].
While the presumed causes of clinical inertia were
widely discussed in a number of articles, considerations
on the definition remained scarce. A few authors pointed
out that there was a need for an accurate definition:
“While there is additional history behind the use of the
terms “clinical inertia” and “therapeutic inertia,” much
of the more recent usage is imprecise. We think that it is
time to use these terms more carefully and more purpose-
fully and to refer to models that have some basis in the-
ory and evidence” [20].
A few specific elements were not clear about Phillips’
definition. Ardery et al. considered that: “Infrequent docu-
mentation of lifestyle recommendations could reflect an-
other type of clinical inertia—namely, missed opportunities
to promote patient self-management” [26]. Gugliano et al.
stated that: “Clinical inertia also may apply to the failure
of physicians to stop or reduce therapy no longer needed”
[22], a situation for which Rodrigo et al. proposed the spe-
cific term “therapeutic momentum” [27], although this
term had already been defined as synonymous to clinical
inertia by Faria et al. [17].
Scheen considered that the actual term “inertia” already
meant “unjustified”: “therapeutic inertia can be defined as
an unjustified delay in treatment initiation or intensifica-
tion”, or “deleterious”: “a caregiver behavior resulting in a
deleterious delay” [21]. The possible occurrence of a justi-
fied or beneficial delay was not discussed in this article.
Looking for an operational definition, O’Connor con-
cluded that: “Flexibility in how clinical inertia is defined
could be seen by some as a limitation. However, from the
point of view of care improvement, this sort of flexibility
may often be an advantage because it allows local tailor-
ing of initiative and interventions.” [28]. The terms re-
trieved and their initial or modified definitions are listed
in Table 1.
Who
All authors agreed that the practitioner had the principal
role in the phenomenon. Nevertheless, many insisted on
the imbrication of the various stakeholders leading to in-
ertia, and on the patient and health system responsibil-
ities. O’Connor et al. proposed a conceptual model that
combined physician, patient, and office and system fac-
tors [28]. The same type of classification emerged from
Table 1 Terms and definitions
Term First occurrence Definition
Clinical inertia Phillips et al.. Ann Intern Med 2001,
135:825–834.
Health care providers often do not initiate or intensify therapy appropriately
during visits of patients with these problems [hypertension, dyslipidemia and
diabetes]. We define such behavior as clinical inertia—recognition of the
problem, but failure to act.
Therapeutic inertia Okonufa et al.. Hypertension 2006,
3:345–351.
Therapeutic inertia (TI), that is, failure of providers to begin new medications or
increase dosages of existing medications when an abnormal clinical parameter
is recorded.
Patient's inertia Vinyoles. Hipertension 2007,
24:91–92.
Three inertias are barriers to change: physician's inertia, patient's inertia, and
health authorities inertia.
(Translated from Spanish)
Health authorities inertia Vinyoles. Hipertension 2007,
24:91–92.
Three inertias are barriers to change: physician's inertia, patient's inertia, and
health authorities inertia.
(Translated from Spanish)
Physician inertia Vinyoles. Hipertension 2007,
24:91–92.
Three inertias are barriers to change: physician's inertia, patient's inertia, and
health authorities inertia.
(Translated from Spanish)
Moser et al.. J Clin Hypertens 2009,
11:1–4.
Physician inertia is defined as the failure to initiate therapy or to intensify or
change therapy in patients with BP values >140 ⁄90 mmHg, or >130⁄80 mm Hg
in hypertensive patients with diabetes, renal, or coronary heart disease.
Clinical Myopia Reach. Diabetes Metab 2008,
34:382–385.
We suggest that a failure to give preference to the long-term benefits of
treatment intensification may represent a common mechanism underlying
both patient non-adherence and physician clinical inertia. We dub such
a failure as “clinical myopia”.
Therapeutic momentum Faria et al.. J Am Soc Hypertens 2009,
3:267–276.
Therapeutic inertia, therapeutic momentum, and physician inertia are all terms
synonymous with clinical inertia
Rodrigo et al.. Int J Clin Pract 2013,
67:97–98.
The reluctance to step down or withdraw therapy when further prescription
is not needed or not supported by evidence. We have termed it ‘therapeutic
momentum’.
Diagnostic inertia Gil-Guillén et al.. Blood Press 2010,
19:3–10.
Diagnostic inertia was defined as a failure to consider the diagnosis of HTN
in a subject in the absence of diagnosis of HTN and elevated BP.
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ping of the categories [29].
Although Phillips, in his initial article, considered that:
“Patient nonadherence cannot explain the failure of pro-
viders to initiate or advance therapy appropriately”, he
also admitted that: “Clinical inertia may also reflect pa-
tients’ lack of enthusiasm for management of asymptom-
atic problem” [10]. The actual complexity of the relation
between the caregiver’s inertia and the patient’s adher-
ence or preferences was often discussed: “the inability to
achieve adequate BP control likely arises through a com-
plex interaction of patient and provider behaviors” [30].
In their attempt to provide a conceptual model for clin-
ical inertia, O’Connor et al. hypothesized that the vari-
ous patient factors involved accounted for 30% of the
whole phenomenon [28]. These factors would include
denial of disease, low health literacy, number, cost and
side effects of medications, and doctor-patient relation-
ship issues. Lin et al. found that patient’s non-adherence
was cited by the physician as the barrier to intensifying
therapy in 19% of the visits, and “other patient factors”
in 49% [31]. Reach proposed a common mechanismleading to physician’s inertia and patient nonadherence
[25]. He defined “clinical myopia” as giving preference
to the immediate and tangible benefits of nonadherence
or inertia, instead of long-term benefits, and hypothe-
sized that these behaviors, sharing the same psycho-
logical structure, enter into resonance. However, the
large retrospective cohort study of Heisler et al. found
that patient adherence had little effect on provider’s de-
cision about intensifying therapy [32].
Office and system factors accounted for 20% of clinical
inertia according to O’Connor et al. [28]. In the qualita-
tive studies, time was an issue raised by many partici-
pants, and systematically related to competing demands
[29,33] . Some authors agreed with O’Connor to regard
this time issue as being a part of clinical inertia and in-
clude it in the “Physician factors”: “Providers often have
competing interests, including lack of time, more urgent
requests made by the patient, and practice habits that
can prohibit the escalation of care when such a modifica-
tion is clinically indicated. This behavior (or lack thereof )
is known as clinical inertia” [34]. Others considered it as
being out of the reach of the practitioner, and therefore
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as lack of time in consultations.” [35]; “The impact of the
medical environment should also be underscored (…)
providers need to have adequate time and resources to
be able to adhere to guidelines and to provide the neces-
sary patient education and counseling” [36].
How and why
Clinical uncertainty regarding BP measurements was con-
sidered in very different ways. Repeated measurement
could be regarded as a need, as stated by general practi-
tioners in a qualitative study: “To monitor therapy more
accurately, more automated machines for home monitor-
ing and greater access to ambulatory BP monitoring were
considered of need” [29], or as a pure waste of time, ac-
cording to Phillips and Twombly answering to criticism
on their editorial: “Our understanding of the basis for clin-
ical inertia has been advanced by the demonstration of
contributions from “clinical uncertainty” and “competing
demands”, but it’s been almost 7 years since the concept
was promulgated. We believe that rather than doing fur-
ther studies on mechanisms, it’s time to focus on overcom-
ing clinical inertia” [37,38].
Acceptable control seemed to have two different ac-
ceptations. The first one was to consider that a BP close
enough to the recommended target was satisfying, and
the other that the actual target for a given patient would
be dictated by the baseline BP [39-42]. Although most
authors considered this behavior as inappropriate and
unjustified, some had slightly different views. Banegas
et al. pointed out that: “In fact, the trial-based differ-
ences in achieved cardiovascular protection within this
range of BP values seem to be small at best” [43]. Dis-
cussing their empirically derived model of “clinical
inaction” Safford et al. noted that: “best level of control
may appropriately differ from patient to patient as
patients increase in complexity, especially in the geri-
atric population” [44]. Others clearly stated that this be-
havior was not inertia. Crowley et al. conclude their
work on hypertension telemanagement with: “However,
when physicians did not intensify treatment, it was be-
cause blood pressure was closer to an acceptable thresh-
old, and repeat blood pressure elevations occurred less
frequently. Failure to intensify treatment when home blood
pressure is elevated may, at times, represent good clinical
judgment, not clinical inertia” [41], and Kennedy and Mac
Lean stated: “It is important to distinguish clinical inertia
from modified therapeutic goals” [45].
Competing demands have proven to contribute con-
sistently to clinical inertia [11,12,46]. In terms of con-
cepts, a controversy between authors summarizes the
problem. Phillips and Twombly proposed in an editor-
ial to overcome the problem by recommending that
physicians “run the numbers first and deal with bloodpressure and glucose before asking about other prob-
lems” [37]. This editorial led to a number of answers.
Among them, Boyd and Leff stated that “this is the
wrong way to frame the issue because it does not ad-
equately acknowledge a patient-centered perspective of
chronic illness care, in which all of the patient’s condi-
tions are considered in terms of the relative benefit of
treating each condition in the presence of the other condi-
tions, the cumulative effect of all the recommended treat-
ments, and the individual’s treatment priorities” [38].
Vijan et al. added that: “If primary care physicians fo-
cused on the numbers first, they would end up imposing
their own priorities onto patients, rather than letting
patients help set the agenda. Consider a visit with a
patient who has depression or chronic pain. Until a
physician addresses such issues, there is little chance of
managing chronic conditions well” [38].
Guidelines skepticism has been widely discussed in a
number of conditions, including hypertension, since
Cabana et al. founding article [47]. This skepticism in-
cludes distrust of the evidence underpinning the guide-
lines, discrepancies between the various guidelines,
unrealistic treatment targets and inappropriateness for
primary care. Each of these factors is controversial:
“clinical inertia may be a clinical safeguard through
which physicians acknowledge the uncertainty in some
current practice guidelines” [22]; “realistic expectations
about the results of adherence to clinical practice guide-
lines are also called for when considering the subject of
possible clinical inertia.” [20]; “clinical inertia or inaction
may actually act as a safeguard for some patients when
overzealous guidelines require treatment before definitive
trials are available” [19]; “in most guidelines, the full
versions make clear that evidence on targets is limited and
their recommendations are unattainable in many pa-
tients” [48]. Borzecki et al. separated guidelines skepticism
from clinical inertia: “The most important provider-related
barriers to adherence to best practice include clinical iner-
tia and lack of provider agreement with guidelines” [36].
Overestimation of care is a well-known phenomenon.
All authors agreed to consider its results as “pure iner-
tia” that should be specifically and systematically ad-
dressed [49,50].
Perceived patient attitude, and notably perceived non-
adherence or unwillingness to take more medications or
to follow counseling, relates to both non-adherence and
doctor-patient relationship. Although cited in many arti-
cles as a cause of inertia, it was very rarely explored, and
even less commented. Campbell made this remark in an
editorial about hypertension guidelines: “Individual pa-
tients vary widely in their perception of acceptable risk
and side effects.(…) Surprisingly, the patient's role in de-
ciding his or her own blood pressure target receives scant
attention in guidelines for hypertension” [48].
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A number of authors insisted that the lack of treatment
intensification for a patient who did not reach the target
BP could actually reflect appropriate care. Various specific
situations involving this issue were already highlighted in
the previous sections. The gap between guidelines and ac-
tual care could be regarded as an appropriate translation
of trials results in real-life: “Sometimes the inertia may be
appropriate. There might be a difference between effects in
controlled trials and effectiveness in primary care patients.
The GP has to take into account all circumstances for each
patient, e.g. other risk factors, concurrent disease, medica-
tions, and function of different organs” [51]; “It is possible
that the guidelines may be correct, but there is also the
possibility that the care by the physicians is appropriate
since BP 130/80 mmHg is hard to achieve, and recent re-
views suggest there is insufficient evidence to support such
a low BP target” [43]. Hicks et al. conducted a prospective
survey on the point of care in hypertensive diabetic pa-
tients. They found that: “26% of patients are ‘near goal’,
and action in this group is infrequent. This phenomenon
has been referred to as ‘clinical inertia’ (…). The reasons
given by providers for no action may reflect an individ-
ualized approach to patient care, rather than an un-
questioned adherence to guidelines. (…)We did not find
evidence for a pattern of a poor quality of care. On the
contrary, providers seemed willing to consider the needs of
their patients and the specific clinical circumstances” [46].
With a nominal group approach, Safford et al. were
able to provide some qualitative evidence on the possible
appropriateness of inaction. Experts voted and agreed on
a number of situations where inaction would be appro-
priate and others on when it would not. After giving
useful clues for further research on the topic, the au-
thors emphasized the need to make the appropriate de-
cision “to not intensify treatment” as clear as possible:
“Distinguishing potential clinical inertia from appropriate
inaction is an important initial step for interventionists
seeking to identify strategies to improve care and for policy
makers seeking to measure quality of health care” [44].
Discussion
Main findings
This review retrieved major discrepancies between the
authors regarding definition and conceptualization of
therapeutic inertia. Opinions differed widely on every
issue, from semantics to the inner quality of inertia re-
garding therapeutic decisions. Whereas some claimed
that the practitioner’s decision should rely on numbers
and numbers only, others regarded inertia as a choice
that could sometimes be reasonable and adequate. On a
more factual level, some suggestions for interventions to
reduce clinical inertia went against the principles of
evidence-based medicine and patient-centered practice,and some studies highlighted behaviors that matched
the definition of therapeutic inertia but were neverthe-
less appropriate.
The reliability of BP measurement is crucial. Nested in
therapeutic inertia as one of its factors, “clinical uncer-
tainty”, defined as the feeling of the physician that the
numbers might not be reliable and therefore the patient
might not be hypertensive, appears to be a concept in it-
self. The diagnosis of hypertension means a lifelong
treatment. The decision to initiate or intensify a treat-
ment requires “certainty”, and emergency is exceptional.
Whether a reasonable delay to secure a diagnosis with
ambulatory measurement is acceptable is not addressed
by the initial definition. In some trials and surveys, such
a delay was regarded as pure inertia. Recent guidelines
have advocated the systematic use of home or ambula-
tory blood pressure monitoring before any treatment ini-
tiation or modification [6]. On the other hand, a delay in
confirmation should remain reasonable, and measure-
ments should not be repeated indefinitely.
Above all, evidence-based practice in primary care
should always remain patient-centered. Treating hyper-
tension in a patient is a matter of numbers. Treating a
hypertensive patient requires a thorough analysis of the
patient’s global health and comorbidities, including psy-
chological and social issues, and shared decision making
on the patient’s expectations as well as the biomedical
data [4,52,53]. Still, there is a risk of abusive reference to
the informal frames of evidence-based practice and
shared decision making to mask unjustified delays.
Our findings suggest that the definition of therapeutic
inertia should take into account the inherent complexity
of primary care situations. Health care system realities
on one side, patients’ values and attitudes on the other,
both interact with the GPs’ behaviours to generate a
complex system, not accounted for by the initial defin-
ition. What is more, this definition did not take into ac-
count the consequences, deleterious, neutral or useful of
inaction.
A definition that merges an unacceptable loss caused
by lack of knowledge, conviction, or time with a legit-
imate demand for reliable data and an appropriate de-
cision is definitely not an operational definition. There
is no sense in trying to reduce a complex phenomenon
without knowing the precise conditions of its occur-
rence and to what extent it can be deleterious or use-
ful. This issue has become increasingly acknowledged
in the most recent articles, with a number of authors
trying to differentiate “pure” inertia from “appropriate”
inaction.
Finally, our main conclusion is that it all comes down
to appropriateness, with regards to both the various
mechanisms of inertia and the patient-centered model of
care (Figure 2).
Figure 2 Model of shared decision-making leading to either
appropriate inaction or inappropriate inertia.
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Semantics should now reflect these findings as clearly as
possible. The words appropriate and inappropriate refer
to neutrality and objectivity, without any judgment qual-
ity or manichaeism attached to them, and reflect a genu-
inely factual approach. We therefore suggest that two
different definitions, one for “appropriate inaction” and
the other for “inappropriate inertia”, should now be de-
veloped. Of course, we realize that a number of items in
this review could be part of either of these two defini-
tions. For example, clinical uncertainty can lead to appro-
priate inaction when blood pressure has been measured
only in the office, and the practitioner claims for a home
or ambulatory measurement, or to inappropriate inertia
when this has been already done twice and yet a third time
is scheduled. Further research is needed to clarify and pre-
cisely define to what extent each of these items should be
accounted for, and achieve a consensus that should rely as
much as possible on an inductive basis and empirical data.
The intimate causes and reasons leading to such be-
haviors should also be explored thoroughly. There is a
major lack of qualitative data in this field. There is no
way behaviors can be changed without prior exploration
of their ins and outs.On these new bases, interventions could be designed
and assessed to either encourage appropriate inaction or
reduce inappropriate inertia.
Strengths and limitations
We followed the PRISMA guidelines as much as pos-
sible, provided that a number of items relate to quantita-
tive systematic reviews and meta-analysis, and therefore
could not be considered for this qualitative review [14].
As already stated, “inertia” is not a MeSH term, which
made the search a bit more difficult and “risky”, and it is
possible that we missed articles discussing the concept
using other terms. We tried to avoid this by elaborating
a search algorithm as sensitive as possible to all aspects
of the concept, and by paying special attention to the
publications cited in references in the selected articles.
Although our concern was general practice, we did not
include any MeSH terms related to primary care. Nar-
rowing the search with such terms would have resulted
in a loss of a few articles of interest, which discussed
theoretical aspects of guideline adherence or inertia re-
gardless of the context of care.
Although relying on a systematic search of the litera-
ture, this research was not a meta-synthesis of qualita-
tive research. We conducted a qualitative analysis of
original articles that could be qualitative research, quan-
titative research or opinion papers. There is no standard
method for this kind of research, and the choice of a
constant comparison qualitative method can be ques-
tionable. Because we were only looking for elements of
definitions and concepts, quality assessment of the stud-
ies described in the selected articles was not justified.
Therefore, the selection of the relevant articles very
much depended on the researchers’ opinions. We tried
to minimize this bias with a systematic blinded selection
process.
We did not systematically search for “grey” literature.
Considering the lack of qualitative research in this re-
view and the wide use of qualitative methods in theses
and dissertations, we might have missed some interest-
ing works. However, it is unlikely that such works would
have dramatically modified the results.
When dealing with definitions and concepts, exploring
the causes (“How and why”) might seem questionable, and
even out of focus. But when it comes to intimate mecha-
nisms of human behaviours, causes and consequences exist
first, and then, possibly, the concept arises. A number of
authors in this review did think about the definition and
the concept starting from observed or assumed causes,
and so their contribution to the conceptualization was in
terms of (possible) causes, which justified the “How and
why” section of the results.
Finally, the extraction of data and their coding is always,
to some extent, affected by the personal understanding of
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and a fifth researcher adjudicated any discrepancies, in
order to minimize this bias.
Conclusion
This systematic review of the literature revealed import-
ant discrepancies, and sometimes antagonisms, regard-
ing the possible causes, inner mechanisms and outcomes
of therapeutic inertia in hypertension. The initial defin-
ition proposed by Phillips, and referred to by most au-
thors, does not take into account the inner complexity
of doctor-patient relationship and shared decision mak-
ing in primary care.
Our data analysis led us to conclude that the concept
of therapeutic inertia should be split into two separate
concepts, namely appropriate inaction and inappropriate
therapeutic inertia. The development of consensual and
operational definitions and the exploration of intimate
mechanisms that underlie these behaviors are now needed.
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